Adarx Pharmaceuticals, Inc.

This study tests a new drug called ADX-038 for people with PNH who still have anemia despite treatment. It first checks safety in healthy adults, then tests the drug in PNH patients. The goal is to see if ADX-038 can safely control the disease and improve red blood cell health.

This study tests a new medicine called ADX-324 for people with hereditary angioedema (HAE), a condition that causes sudden, painful swelling attacks. The drug uses a technology called siRNA to lower a protein involved in triggering attacks. About 90 adults with HAE type 1 or 2 wi…

This study tests an investigational drug called ADX-038 in 240 people with geographic atrophy, an advanced form of dry age-related macular degeneration that causes blind spots. The drug is given as a shot under the skin and is compared to a placebo to see if it can slow the loss …

This early-stage study tests the safety of a new drug called ADX-626 in 44 healthy adults aged 18 to 45. Researchers will monitor side effects and measure how the drug moves through the body. No treatment benefit is expected; the goal is to gather essential safety data before tes…